CCN5 Activation by free or encapsulated-EGCG is required to Render Triple-negative breast cancer cell Viability and Tumor Progression
Amlan Das(National Institute of Biomedical Genomics), Sushanta K. Banerjee(Kansas City VA Medical Center)
Cited by 20
Related Papers
The Impact of Nanoparticles on the Immune System: A Gray Zone of Nanomedicine
|Journal of Immunological Sciences|2021|136
Thombospondin-1 Disrupts Estrogen-Induced Endothelial Cell Proliferation and Migration and Its Expression Is Suppressed by Estradiol
|Molecular Cancer Research|2004|58
Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth
|Scientific Reports|2017|31